This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by O'Brien, D. W. Articles by Jugdutt, B. I. Search for Related Content PubMed Articles by O'Brien, D. W. Articles by Jugdutt, B. I. Social Bookmarking                         What's this?

Efficacy of Pretreatment With the Angiotensin II Type 1 Receptor Blocker UP269-6 and Losartan in the Dog: Effect on Hemodynamics and Ischemia-Reperfusion

Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada

Yi Xu

Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada

Vijayan Menon

Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada

Bodh I. Jugdutt

Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada

Background: Whether pretreatment with the novel oral angiotensin II (AngII) type 1 receptor (AT,R) antagonist UP269-6 (UP) can produce more effective AT,R blockade than losartan (LN) for cardioprotection during ischemia-reperfusion (IR) in the dog has not been deter mined.

Methods and Materials: We compared the effect of UP (n = 5) and LN (n = 5) on serial in vivo hemodynamics, AngII pressor responses, and left ventricular (LV) volumes and function (echocardiograms) during escalation to optimal oral dosage over 7 days (day 0 to day 6), and acute IR (15 minutes ischemia, 30 minutes reperfusion) and ex vivo AT,R protein (Western immunoblots) with additional sham (n = 5) and IR (n = 5) controls on day 6. Compared with LN, UP produced greater vasodepression and decrease in diastolic volume during dose escalation and greater inhibition of the AngII pressor response over the range of escalating concentrations (0.05, 0.10, 0.25, and 0.50 µg/kg) on day 6. Acute IR after UP pretreatment resulted in less increase in LV filling pressure and LV diastolic and systolic volumes and greater ejection fraction, although UP and LN had similar effects on AT,R protein.

Conclusion: Pretreatment with UP269-6 over 7 days produces more effective pharmacologi cal AT,R blockade and cardioprotection after acute IR than LN in the dog.

Key Words: angiotensin II • AT1 receptor protein • hemodynamics • echocardiograms.

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 5, No. 2, 129-137 (2000)
DOI: 10.1053/XV.2000.5591


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?